A CEO's Guide to Molecular Diagnostic Reimbursement
Navigating the Many Challenges of Reimbursement and Commercialization
Reimbursement and commercialization are significant challenges in this era of personalized medicine and comparative effectiveness. Many traditional clinical laboratories and early stage start-up companies are trying to enter this space and are struggling to evaluate both the market and its offerings.
This white paper specifically addresses:
The following are some of the questions to consider when creating a business plan for commercialization of a genetic test: